The care-afterwards chapter
What if something feels wrong?
Before a plan begins, ask who will answer questions later. Keep that answer somewhere easy to find.
Before the plan begins
Agree how to get an answer
Ask who reads messages, when to expect a reply and how the next review will be arranged.
After medicine arrives
Keep a clinician in reach
In guidance checked September 17, 2026, the U.S. Food and Drug Administration (FDA) flags services with no doctor available for questions after medicine arrives. note a
Check the label and delivery against the medicine’s instructions
Compounded describes how the drug is prepared: it is made to order.
Reports received by FDA as of September 26, 2026 described possible errors in amounts of compounded semaglutide, with some cases requiring hospital care. note a
Ask the health professional who ordered the medicine or the pharmacist to explain unclear instructions.
Check the delivery against the product’s instructions
Peptide medicines do not all share the same storage needs.
The product’s own label and the pharmacy’s instructions are the reference for storage. note b
GLP-1 drugs, including semaglutide, imitate a bodily signal used in the control of blood sugar and hunger.
FDA advises people not to use a GLP-1 injection delivered warm or without enough cooling. note a
When the next step is emergency help
Breathing or swallowing trouble, or a tongue or face that becomes swollen, may mean a severe allergic reaction is happening.
The U.S. National Institutes of Health (NIH) calls this reaction a life-threatening emergency.
Seek emergency medical help for severe symptoms. note c
Tell the clinician; a report can also reach FDA
MedWatch is FDA’s public service where patients can submit reports about medicine problems. note d
Submitting a medicine-problem report does not establish that the drug caused what happened.
Save the drug’s name and label, along with your account of what happened, to discuss with the clinician.
Sources behind this chapter
- FDA: delivery, follow-up and compounded weight drugs
The delivery guidance was checked September 17, 2026; the dosing-error reports were checked September 26, 2026.
- NIH: information for semaglutide injection
These storage details concern a particular medicine, not all peptides.
- NIH: severe allergic reactions and emergency help
The emergency-help information was checked September 17, 2026.
- FDA: the MedWatch reporting service
Health professionals and patients can both use this reporting route.